Showing results (21-30 of 1,242) with videos related to

Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 5, 2016
Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregiversMeredith Bock, Y-Nhy Duong, Anthony Kim, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 5, 2016
Screening of the TBK1 gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese originShi Shu, Xiao Ling Li, Qing Liu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 2, 2017
Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutationsFabio Coppedè, Andrea Stoccoro, Lorena Mosca, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 2, 2017
Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolmentBello Hamidou, Benoit Marin, Geraldine Lautrette, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2017
An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and EuropeKoji Takei, Kikumi Tsuda, Fumihiro Takahashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2017
Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosisKoji Takei, Fumihiro Takahashi, Shawn Liu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2017
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2016
Selective attention impairment in amyotrophic lateral sclerosisChiara Volpato, Maria Angeles Prats Sedano, Stefano Silvoni, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 20, 2016
The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytesMilena Milošević, Danijela Bataveljić, Ljiljana Nikolić, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 25, 2016
Neuropsychological assessment in different King's clinical stages of amyotrophic lateral sclerosisFrancesca Trojsi, Gabriella Santangelo, Giuseppina Caiazzo, et al.
Pageof 125